Drug Discovery Today logo Elsevier logo

Publisher: Elsevier

Volume 1, Number 2, February 1996
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

next issue > | all issues

Modified transcriptional activators as therapeutic tools
pp. 50+52-50+52(1)
Author: White J.H.

Automated lead discovery
pp. 46-46(1)
Author: Wallace R.W.

Combinatorial biology
pp. 48-49(2)
Author: Wallace R.W.

New Alzheimer's model from Japan
pp. 49-49(1)
Author: Jack D.B.

Better use aspirin
pp. 49-50(2)
Author: Bradley D.

People
pp. 52-52(1)
Author: Jack D.B.

CAS record
pp. 52-52(1)
Author: Hughes D.

New approach to drug therapy in Alzheimer's dementia
pp. 53-59(7)
Authors: Maelicke A.; Albuquerque E.X.

Squalene synthase inhibitors
pp. 82-82(1)
Authors: Brown G.R.; Harris G.H.

Acyl-CoA:cholesterol acyltransferase inhibitors
pp. 82-82(1)
Author: Roth B.D.

Dopamine D3-antagonists and partial agonists
pp. 82-82(1)
Author: Wright J.

2,4-Diaminopyrrolo-[2,3-d]pyrimidines
pp. 83-83(1)
Author: Bundy G.L.

Selective 5-HT4 receptor antagonists
pp. 83-83(1)
Author: Buchheit K.-H.

alpha-Alkylated gamma,delta-unsaturated amino acids
pp. 83-83(1)
Authors: Kazmaier U.; Maire S.

N-Acetyl-alpha-d mannosamine 1-phosphate analogues
pp. 83-83(1)
Author: Cipolla L.

Synthesis of pyrrolo [2,3-d]pyrimidines
pp. 83-84(2)
Authors: Taylor E.C.; Patel H.H.; Jun J.G.

Chiral boron enolates
pp. 84-84(1)
Authors: Gennari C.; Pain G.; Moresca D.

Synthesis of l-(+)-ergothioneine
pp. 84-84(1)
Authors: Xu J.; Yadan J.C.

next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A